Overview

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Furt

Status:
Terminated

Trial end date:
2016-07-22

Target enrollment:

Participant gender:

Summary

Investigation of pharmacological effects, drug blood levels and safety of an intrauterine system releasing the study drug BAY1007626 in comparison to Mirena and Jaydess in healthy young women treated for 90 days to determine the drug dose for further development

Phase:

Phase 2

Details

Lead Sponsor:

Bayer

Treatments:

Levonorgestrel